Kevin Blauth

Kevin Blauth is a Medical Director at Amylyx Pharmaceuticals with extensive experience in medical science liaison roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Actelion. Prior to their industry roles, Kevin also served as an Adjunct Assistant Professor at Regis University and an Instructor at the University of Colorado Anschutz Medical Campus. Kevin's research focus has been on the development and application of B cell- and Immunoglobulin G-driven models of Multiple Sclerosis, with a strong commitment to mentoring junior level researchers. Kevin holds a Doctor of Philosophy (Ph.D.) in Cell and Molecular Neurobiology from the University of North Carolina at Chapel Hill.